BackgroundCheck.run
Search For

Suzanne B Hendrix, 562180 E Claybourne Ave, Salt Lake City, UT 84109

Suzanne Hendrix Phones & Addresses

2180 Claybourne Ave, Salt Lake Cty, UT 84109    801-4867467    801-4847467   

Salt Lake City, UT   

Logan, UT   

Provo, UT   

452 520 E, Orem, UT 84097    801-2211055   

Framingham, MA   

Willoughby Hills, OH   

Mentions for Suzanne B Hendrix

Suzanne Hendrix resumes & CV records

Resumes

Suzanne Hendrix Photo 37

Owner And Operator

Work:
Squeaky Cleaners Additions
Alterations, Sewing, Laundry and Ironing
Cleaners
Owner and Operator
Lickstone Farm 1993 - May 2014
Owner and Operator
Senior Resource Center Waynesville 2009 - 2013
Crc For State of Nc, Event Coordinator and Planner
Lickstone Child Care 1996 - 2004
Owner Operator
Hand Knit and Crochet Custom Clothing 1996 - 2004
Individual
Skills:
Microsoft Office, Microsoft Word, Microsoft Excel, Customer Service, Research, Outlook, Photoshop, Html, Public Speaking, Powerpoint, Strategic Planning, Editing, Team Building, Social Media, Event Planning
Suzanne Hendrix Photo 38

Chief Executive Officer And President

Location:
Salt Lake City, UT
Industry:
Pharmaceuticals
Work:
Pentara Corporation since Mar 2008
President
Myriad Genetics 2002 - 2008
Director Biostatistics
Myriad Pharmaceuticals 2002 - 2008
Director Biostatistics
Women's Research Institute of BYU 2000 - 2002
researcher
Brigham Young University 1997 - 2002
Instructor
Parexel 1996 - 1999
Biostatistician
Astra 1995 - 1999
Biostatistician
Genzyme 1997 - 1997
Biostatistician
Muro Pharmaceuticals 1995 - 1996
Biostatistician
Serono Laboratories 1994 - 1995
Biostatistician
Astra Pharmaceuticals 1994 - 1995
statistician
Medical & Technical Research Associates,Inc. 1991 - 1995
Statistician
MTRA 1990 - 1994
Biostatistician
Education:
Boston University 1992 - 1996
Doctor of Philosophy (Ph.D.), Mathematics, Statistics
Brigham Young University
Bachelor of Science (B.S.), Statistics
Skills:
Biostatistics, Clinical Trials, Clinical Study Design, Clinical Development, Pharmaceutical Industry, Sas Programming, Clinical Research, Statistics, Drug Development, Data Analysis, Sas, Neuroscience, Biotechnology, Alzheimer's Disease, Healthcare, Cro, Lifesciences
Suzanne Hendrix Photo 39

Suzanne Hendrix

Suzanne Hendrix Photo 40

Marketing Director

Position:
Marketing Director/ Multimedia Producer at Nova USA
Location:
Portland, Oregon
Industry:
Marketing and Advertising
Work:
Nova USA - Portland, Oregon since May 2012
Marketing Director/ Multimedia Producer
Your Reel Life - Porland Oregon Aug 2010 - May 2012
Freelance Producer/ Video Editor
LatinWorks - Hispanic Agency of the Year - Austin, Texas Aug 2005 - Jul 2010
Senior Media Producer
JGA Productions, Austin, TX - Austin, Texas Jul 2004 - Aug 2005
Freelance Film Editor
Relativity Productions, Austin, TX - Austin, Texas Jan 1996 - Jul 2004
President
Education:
Academy of Art University
Austin Community College
Skills:
Mac OS X, Windows 95/98/XP/Vista, Final Cut Pro, Adobe Creative Suite CS2/CS3, Adobe Acrobat, Cleaner, Microsoft Office Suite (Word, Excel, Access, Powerpoint), Filemaker Pro, Quicktime, SnapZ Pro, Photomatrix Pro, DVD Studio Pro, Keynote, Digital photography, Black & White Photography, Photo Retouching, Photo Resizing, Image Preparation, HD, HDV, mp3, AAC, Mpeg and Flash file compression and encoding/codecs, Google Adwords, InDesign, Video Editing, Producing, Video Production, Advertising, Post Production, Creative Direction, Social Media, Social Media Marketing, Microsoft Excel, Microsoft Word, PowerPoint, Online Marketing, Video, Photography, Editing, Television, Film, Public Relations, Commercials, Marketing, Documentaries, Adobe Creative Suite
Interests:
Writing, traveling, a good cup of coffee, camping, windsurfing, National Geographic, photography, yoga, running, road trips, dry sense of humor and organic gardening

Publications & IP owners

Us Patents

Statistical Comparator Interface

US Patent:
2003011, Jun 19, 2003
Filed:
Oct 28, 2002
Appl. No.:
10/281894
Inventors:
Bruce Brown - Provo UT, US
Kent Hendrix - Salt Lake City UT, US
Suzanne Hendrix - Salt Lake City UT, US
International Classification:
G06T015/00
US Classification:
345/419000
Abstract:
A Statistical Comparator Interface provides a user with the capability to reduce vast amounts of raw data into a readily navigable and quickly comprehendible form. The Statistical Comparator Interface is embodied in two basic stages. In a data compilation stage, a compilation module, which is preferably implemented with computer software, receives the raw data and compiles the raw data into a format that is readily navigable by a navigation engine. This may include expanding the data through statistical computations and arranging the data in a data matrix complete with hierarchal indices. In a navigation stage, the navigation engine is employed to allow a user to generate data profiles from among the formatted data, including selecting a peer group with selected characteristics and selecting statistical comparisons to be calculated and displayed for the selected peer group. The navigation stage may also allow the user to select from among a plurality of graphical depiction schemes to display the selected statistical comparisons in a manner that is readily comprehendible to a lay, unindoctrinated user. The graphical display schemes preferably employ multivariate statistical methods such as MANOVA, discriminate analysis, multivariate multiple regression, etc., and multivariate graphing methods such as three-dimensional scatter plots and ordered profile surfaces to display the highly complex data in a readily understandable format.

Pharmaceutical Methods, Dosing Regimes And Dosage Forms For The Treatment Of Alzheimer's Disease

US Patent:
2005004, Feb 24, 2005
Filed:
Jul 12, 2004
Appl. No.:
10/889971
Inventors:
Adrian Hobden - Salt Lake City UT, US
Kenton Zavitz - Salt Lake City UT, US
Gary Mather - Salt Lake City UT, US
Suzanne Hendrix - Salt Lake City UT, US
Assignee:
Myriad Genetics, Incorporated - Salt Lake City UT
International Classification:
A61K009/20
A61K031/192
US Classification:
424464000, 514571000
Abstract:
In general, the invention relates to a pharmaceutical dose having R-flurbiprofen as the active ingredient that upon oral administration of a single dose to a fasting subject provides a Cof about 30-95 μg per mL. When the dose is administered to an individual having mild-to-moderate Alzheimer's disease (or desiring protection against Alzheimer's disease) twice daily for at least 4 months according to the described guidelines, an improvement or lessening in decline of cognitive function as characterized by cognition tests is observed in the patient. The composition of the invention is formulated with one or more pharmaceutically acceptable excipients, salts or carriers.

Pharmaceutical Methods, Dosing Regimes And Dosage Forms For The Treatment Of Alzheimer's Disease

US Patent:
2007023, Oct 11, 2007
Filed:
Mar 1, 2007
Appl. No.:
11/681082
Inventors:
Adrian Hobden - Salt Lake City UT, US
Kenton Zavitz - Salt Lake City UT, US
Gary Mather - Salt Lake City UT, US
Suzanne Hendrix - Salt Lake City UT, US
Assignee:
Myriad Genetics, Incorporated - Salt Lake City UT
International Classification:
A61K 31/192
A61P 25/28
US Classification:
514568000
Abstract:
In general, the invention relates to a pharmaceutical dose having R-flurbiprofen as the active ingredient that upon oral administration of a single dose to a fasting subject provides a Cof about 30-95 μg per mL. When the dose is administered to an individual having mild-to-moderate Alzheimer's disease (or desiring protection against Alzheimer's disease) twice daily for at least 4 months according to the described guidelines, an improvement or lessening in decline of cognitive function as characterized by cognition tests is observed in the patient. The composition of the invention is formulated with one or more pharmaceutically acceptable excipients, salts or carriers.

Pharmaceutical Methods, Dosing Regimes And Dosage Forms For The Treatment Of Alzheimer's Disease

US Patent:
2007023, Oct 11, 2007
Filed:
Feb 28, 2007
Appl. No.:
11/680436
Inventors:
Adrian Hobden - Salt Lake City UT, US
Kenton Zavitz - Salt Lake City UT, US
Gary Mather - Salt Lake City UT, US
Suzanne Hendrix - Salt Lake City UT, US
Assignee:
Myriad Genetics, Incorporated - Salt Lake City UT
International Classification:
A61K 31/192
A61P 25/28
US Classification:
514570000
Abstract:
In general, the invention relates to a pharmaceutical dose having R-flurbiprofen as the active ingredient that upon oral administration of a single dose to a fasting subject provides a Cof about 30-95 μg per mL. When the dose is administered to an individual having mild-to-moderate Alzheimer's disease (or desiring protection against Alzheimer's disease) twice daily for at least 4 months according to the described guidelines, an improvement or lessening in decline of cognitive function as characterized by cognition tests is observed in the patient. The composition of the invention is formulated with one or more pharmaceutically acceptable excipients, salts or carriers.

Pharmaceutical Methods, Dosing Regimes And Dosage Forms For The Treatment Of Alzheimer's Disease

US Patent:
2007029, Dec 20, 2007
Filed:
May 8, 2007
Appl. No.:
11/745928
Inventors:
Adrian Hobden - Salt Lake City UT, US
Kenton Zavitz - Salt Lake City UT, US
Gary Mather - Salt Lake City UT, US
Suzanne Hendrix - Salt Lake City UT, US
Assignee:
Myriad Genetics, Incorporated - Salt Lake City UT
International Classification:
A61K 31/19
A61P 25/28
US Classification:
514570000
Abstract:
In general, the invention relates to a pharmaceutical dose having R-flurbiprofen as the active ingredient that upon oral administration of a single dose to a fasting subject provides a Cof about 30-95 μg per mL. When the dose is administered to an individual having mild-to-moderate Alzheimer's disease (or desiring protection against Alzheimer's disease) twice daily for at least 4 months according to the described guidelines, an improvement or lessening in decline of cognitive function as characterized by cognition tests is observed in the patient. The composition of the invention is formulated with one or more pharmaceutically acceptable excipients, salts or carriers.

Treatment Of Psychiatric Disorders

US Patent:
2008003, Feb 7, 2008
Filed:
Jul 9, 2007
Appl. No.:
11/774692
Inventors:
Mark Laughlin - Sunnyvale CA, US
Kenton Zavitz - Salt Lake City UT, US
Suzanne Hendrix - Salt Lake City UT, US
Assignee:
Myriad Genetics, Incorporated - Salt Lake City UT
International Classification:
A61K 31/19
A61P 25/00
US Classification:
514568000
Abstract:
The invention relates to the treatment of psychiatric disorders.

Pharmaceutical Methods, Dosing Regimes And Dosage Forms For The Treatment Of Alzheimer's Disease

US Patent:
2008005, Feb 28, 2008
Filed:
May 2, 2007
Appl. No.:
11/743522
Inventors:
Adrian Hobden - Salt Lake City UT, US
Kenton Zavitz - Salt Lake CIty UT, US
Gary Mather - Salt Lake City UT, US
Suzanne Hendrix - Salt Lake City UT, US
Assignee:
Myriad Genetics, Incorporated - Salt Lake City UT
International Classification:
A61K 31/19
A61P 25/28
US Classification:
514568000
Abstract:
In general, the invention relates to a pharmaceutical dose having R-flurbiprofen as the active ingredient that upon oral administration of a single dose to a fasting subject provides a Cof about 30-95 μg per mL. When the dose is administered to an individual having mild-to-moderate Alzheimer's disease (or desiring protection against Alzheimer's disease) twice daily for at least 4 months according to the described guidelines, an improvement or lessening in decline of cognitive function as characterized by cognition tests is observed in the patient. The composition of the invention is formulated with one or more pharmaceutically acceptable excipients, salts or carriers.

Statistical Comparator Interface

US Patent:
6473080, Oct 29, 2002
Filed:
Mar 9, 1999
Appl. No.:
09/264972
Inventors:
Bruce Leonard Brown - Provo UT
Kent Allen Hendrix - Orem UT
Suzanne Brown Hendrix - Orem UT
Assignee:
Baker Taylor, Inc. - Charlotte NC
International Classification:
G06T 1500
US Classification:
345419
Abstract:
A Statistical Comparator Interface provides a user with the capability to reduce vast amounts of raw data into a readily navigable and quickly comprehendible form. The Statistical Comparator Interface is embodied in two basic stages. In a data compilation stage, a compilation module, which is preferably implemented with computer software, receives the raw data and compiles the raw data into a format that is readily navigable by a navigation engine. This may include expanding the data through statistical computations and arranging the data in a data matrix complete with hierarchal indices. In a navigation stage, the navigation engine is employed to allow a user to generate data profiles from among the formatted data, including selecting a peer group with selected characteristics and selecting statistical comparisons to be calculated and displayed for the selected peer group. The navigation stage may also allow the user to select from among a plurality of graphical depiction schemes to display the selected statistical comparisons in a manner that is readily comprehendible to a lay, unindoctrinated user. The graphical display schemes preferably employ multivariate statistical methods such as MANOVA, discriminate analysis, multivariate multiple regression, etc.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.